Article Information
History
- July 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Leila Y. Chihab1,2,
- Rebecca Kuan1,
- Elizabeth J. Phillips3,4,
- Simon A. Mallal3,4,
- Virginie Rozot5,
- Mark M. Davis6,7,
- Thomas J. Scriba5,
- Alessandro Sette1,8,
- Bjoern Peters1,8,
- Cecilia S. Lindestam Arlehamn1,*,
- the SATVI Study Group
- 1Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA
- 2Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093, USA
- 3Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA 6150, Australia
- 4Vanderbilt University School of Medicine, Nashville, TN 37235, USA
- 5South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
- 6Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
- 7Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA
- 8Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA
- ↵*Corresponding author Cecilia S. Lindestam Arlehamn, Email: cecilia{at}lji.org
Posted July 10, 2022.
Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile
